Cheshire, CT, United States of America

Bijan Almassian

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Aria Neurosciences Inc., Carogen Corporation, New York University. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bijan Almassian. Retrieved from https://idiyas.com/inventor/bijan-almassian

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Bijan Almassian

Introduction

Bijan Almassian is an accomplished inventor based in Cheshire, Connecticut, known for his significant contributions to the field of pharmaceuticals. With a total of two patents to his name, Almassian has focused on developing compounds that address critical health conditions affecting mammals, including humans.

Latest Patents

Almassian's latest patents include innovative compounds and methods aimed at treating various medical conditions. One of his notable patents is for Pyridyl-2-methylamino compounds, which are designed for the prevention and treatment of conditions such as Alzheimer's Disease, Down's syndrome, and Parkinson's Disease. The compounds are defined by a specific formula and are intended to provide therapeutic benefits in a range of applications. Another significant patent involves methods of treating ischemia-related conditions through the administration of thiosemicarbazone compounds. This invention addresses a variety of ischemic conditions, including those related to Alzheimer's disease, Parkinson's disease, and various forms of cerebral ischemia.

Career Highlights

Throughout his career, Bijan Almassian has worked with notable organizations, including Aria Neurosciences Inc. and New York University. His work has contributed to advancements in the understanding and treatment of neurological disorders, showcasing his commitment to improving health outcomes.

Collaborations

Almassian has collaborated with esteemed colleagues such as Martin J. Sadowski and Xu Kevin Lin, further enhancing the impact of his research and innovations in the field.

Conclusion

Bijan Almassian's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a dedication to addressing complex health challenges, making a meaningful difference in the lives of many.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…